Search research articles
Contact Us
Filters
Showing results (21-30 of 283) with videos related to
Page
of 29
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
June 11, 2003
From clinical and pathologic to molecular staging of lung cancer
Pierre P Massion, David P Carbone
Journal of Thoracic Disease
|
May 20, 2017
Non-small cell lung cancer genomics around the globe: focus on ethnicity
Luiz H Araujo, David P Carbone
Lung Cancer (Amsterdam, Netherlands)
|
March 1, 2023
Patients' voice and passion lead to successful clinical trial, KISEKI study; Comments on "A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKIs and platinum-based chemotherapy"
Naoki Furuya, Kai He, David P Carbone
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 20, 2023
Response to the Letter to the Editor Titled "First-Line Nivolumab Plus Ipilimumab With Chemotherapy for Metastatic NSCLC: The Updated Outcomes From CheckMate 9LA"
Luis G Paz-Ares, David P Carbone
Molecular & Cellular Oncology
|
February 22, 2019
Novel mechanism of resistance to targeted therapies in lung cancer
Walter Wang, David P Carbone, Rajeswara Rao Arasada
Progress in Tumor Research
|
September 19, 2015
Promise of Immunotherapy in Lung Cancer
Anil Shanker, Mikhail M Dikov, David P Carbone
Novartis Foundation Symposium
|
November 26, 2004
Genetic blockade of the insulin-like growth factor 1 receptor for human malignancy
Yasushi Adachi, Choon-Taek Lee, David P Carbone
Nature Reviews. Cancer
|
April 3, 2003
Improving the evaluation of new cancer treatments: challenges and opportunities
Mace L Rothenberg, David P Carbone, David H Johnson
Molecular and Clinical Oncology
|
June 8, 2017
Ibuprofen and fatal lung cancer: A brief report of the prospective results from the Third National Health and Nutrition Examination Survey (NHANES III)
Marisa A Bittoni, David P Carbone, Randall E Harris
Therapeutic Advances in Medical Oncology
|
September 4, 2012
Sonic hedgehog pathway expression in non-small cell lung cancer
Malvi Savani, Yan Guo, David P Carbone, et al.
Page
of 29
Search research articles
Search
Showing results (21-30 of 283) with videos related to
Sort By:
Page
of 29
American Journal of Respiratory and Critical Care Medicine
|
June 11, 2003
From clinical and pathologic to molecular staging of lung cancer
Pierre P Massion, David P Carbone
Journal of Thoracic Disease
|
May 20, 2017
Non-small cell lung cancer genomics around the globe: focus on ethnicity
Luiz H Araujo, David P Carbone
Lung Cancer (Amsterdam, Netherlands)
|
March 1, 2023
Patients' voice and passion lead to successful clinical trial, KISEKI study; Comments on "A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKIs and platinum-based chemotherapy"
Naoki Furuya, Kai He, David P Carbone
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 20, 2023
Response to the Letter to the Editor Titled "First-Line Nivolumab Plus Ipilimumab With Chemotherapy for Metastatic NSCLC: The Updated Outcomes From CheckMate 9LA"
Luis G Paz-Ares, David P Carbone
Molecular & Cellular Oncology
|
February 22, 2019
Novel mechanism of resistance to targeted therapies in lung cancer
Walter Wang, David P Carbone, Rajeswara Rao Arasada
Progress in Tumor Research
|
September 19, 2015
Promise of Immunotherapy in Lung Cancer
Anil Shanker, Mikhail M Dikov, David P Carbone
Novartis Foundation Symposium
|
November 26, 2004
Genetic blockade of the insulin-like growth factor 1 receptor for human malignancy
Yasushi Adachi, Choon-Taek Lee, David P Carbone
Nature Reviews. Cancer
|
April 3, 2003
Improving the evaluation of new cancer treatments: challenges and opportunities
Mace L Rothenberg, David P Carbone, David H Johnson
Molecular and Clinical Oncology
|
June 8, 2017
Ibuprofen and fatal lung cancer: A brief report of the prospective results from the Third National Health and Nutrition Examination Survey (NHANES III)
Marisa A Bittoni, David P Carbone, Randall E Harris
Therapeutic Advances in Medical Oncology
|
September 4, 2012
Sonic hedgehog pathway expression in non-small cell lung cancer
Malvi Savani, Yan Guo, David P Carbone, et al.
Page
of 29